|4Dec 15, 5:38 PM ET

HADDEN JOHN 4

4 · PLx Pharma Inc. · Filed Dec 15, 2020

Insider Transaction Report

Form 4
Period: 2020-12-14
HADDEN JOHN
Director
Transactions
  • Purchase

    Common Stock

    2020-12-14$5.42/sh+600$3,2523,290 total
  • Purchase

    Common Stock

    2020-12-14$5.49/sh+400$2,1963,690 total

Documents

1 file
  • 4
    form411577002_12152020.xmlPrimary

    OWNERSHIP DOCUMENT